Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients

NCT04423939 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04423939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04423939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
October 14, 2020
Completion date
February 1, 2025
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic steam cell transplantation (hct)